These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 25945031

  • 1. Keratoprostheses for corneal blindness: a review of contemporary devices.
    Avadhanam VS, Smith HE, Liu C.
    Clin Ophthalmol; 2015; 9():697-720. PubMed ID: 25945031
    [Abstract] [Full Text] [Related]

  • 2.
    Fu L, Hollick EJ.
    ; 2024 01. PubMed ID: 33760451
    [Abstract] [Full Text] [Related]

  • 3. A brief review of Boston type-1 and osteo-odonto keratoprostheses.
    Avadhanam VS, Liu CS.
    Br J Ophthalmol; 2015 Jul; 99(7):878-87. PubMed ID: 25349081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Keratoprosthesis: Current Choices and Future Development.
    Zarei-Ghanavati M, Liu C.
    Asia Pac J Ophthalmol (Phila); 2019 Jul; 8(6):429-431. PubMed ID: 31789643
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Long-term outcome of keratoprosthesis with biological support].
    Hille K.
    Ophthalmologe; 2018 Jan; 115(1):5-11. PubMed ID: 28484851
    [Abstract] [Full Text] [Related]

  • 11. Comparison of long-term results between osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis.
    Charoenrook V, Michael R, de la Paz MF, Temprano J, Barraquer RI.
    Ocul Surf; 2018 Apr; 16(2):259-264. PubMed ID: 29501483
    [Abstract] [Full Text] [Related]

  • 12. [Clinical management of severe ocular surface disease].
    Stoiber J, Grabner G.
    Klin Monbl Augenheilkd; 2005 Jul; 222(7):533-51. PubMed ID: 16034721
    [Abstract] [Full Text] [Related]

  • 13. Osteo-odonto-, Tibial bone and Boston keratoprosthesis in clinically comparable cases of chemical injury and autoimmune disease.
    de la Paz MF, Salvador-Culla B, Charoenrook V, Temprano J, Álvarez de Toledo J, Grabner G, Michael R, Barraquer RI.
    Ocul Surf; 2019 Jul; 17(3):476-483. PubMed ID: 30986549
    [Abstract] [Full Text] [Related]

  • 14. Medium term results in keratoprostheses with biocompatible and biological haptic.
    Hille K, Hille A, Ruprecht KW.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):696-704. PubMed ID: 16308693
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Indications for orbital decompression for patients undergoing keratoprosthesis surgery.
    Norris JH, Carpenter D, Al Raqqad N, Brittain P, Daya S, Liu C, Malhotra R.
    Ophthalmic Plast Reconstr Surg; 2012 Jun; 28(5):346-9. PubMed ID: 22820446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Scanning Electron Microscopic Analysis of Biofilm Formation in Explanted Human Boston Type I Keratoprostheses.
    Sivaraman KR, Hou JH, Chang JH, Behlau I, Cortina MS, Cruz Jde L.
    Cornea; 2016 Jan; 35(1):25-9. PubMed ID: 26562818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.